We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+4.84%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.69%
AUM
$1.58B
AUM Growth
+$210M
Cap. Flow
+$71.1M
Cap. Flow %
4.5%
Top 10 Hldgs %
18.14%
Holding
221
New
32
Increased
92
Reduced
20
Closed
27

Top Buys

Rank Stock Value
1
ASND icon
Ascendis Pharma A/S
ASND
+$12.6M
2
PIII icon
P3 Health Partners
PIII
+$10.1M
3
MRVI icon
Maravai LifeSciences
MRVI
+$9.23M
4
NARI
Inari Medical, Inc. Common Stock
NARI
+$8.99M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$8.85M

Top Sells

Rank Stock Value
1
AMRS
Amyris Inc.
AMRS
+$13M
2
DMTK
DermTech, Inc. Common Stock
DMTK
+$12.9M
3
OSH
Oak Street Health, Inc.
OSH
+$11.8M
4
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
+$9.93M
5
DNA icon
Ginkgo Bioworks
DNA
+$8.89M

Sector Composition

Rank Sector Weight
1 Healthcare 30.22%
2 Technology 18.11%
3 Financials 10.26%
4 Industrials 8.95%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$34.2M 2.16%
652,886
+39,674
+6% +$1.67M
LSCC icon
2
Lattice Semiconductor
LSCC
$18B
$33.9M 2.14%
439,267
+78,691
+22% +$5.84M
MPWR icon
3
Monolithic Power Systems
MPWR
$66B
$33.1M 2.09%
67,008
+11,741
+21% +$6.06M
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$31.3M 1.98%
226,871
+24,966
+12% +$3.17M
KRNT icon
5
Kornit Digital
KRNT
$734M
$31M 1.96%
203,937
-10,008
-5% -$1.54M
ARGX icon
6
argenx
ARGX
$52B
$26.4M 1.67%
75,432
+20,134
+36% +$6.12M
RGEN icon
7
Repligen
RGEN
$8.3B
$25.9M 1.64%
97,752
+9,131
+10% +$2.46M
WAL icon
8
Western Alliance Bancorporation
WAL
$9.04B
$24.1M 1.52%
223,695
+60,871
+37% +$6.85M
WSC icon
9
WillScot Mobile Mini Holdings
WSC
$4.66B
$23.7M 1.5%
581,220
+61,143
+12% +$2.26M
AVTR icon
10
Avantor
AVTR
$9.25B
$23M 1.46%
546,974
+99,432
+22% +$3.92M
ARNA
11
DELISTED
Arena Pharmaceuticals Inc
ARNA
$22.2M 1.41%
239,119
+39,709
+20% +$2.62M
ESI icon
12
Element Solutions
ESI
$9.18B
$21.9M 1.38%
900,607
+225,856
+33% +$5.33M
EXE
13
Expand Energy Corp
EXE
$21.9B
$20M 1.27%
309,987
+90,442
+41% +$5.74M
MRTX
14
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$18.8M 1.19%
128,125
+8,102
+7% +$1.26M
TFII icon
15
TFI International
TFII
$11.1B
$18.7M 1.19%
167,221
+11,682
+8% +$1.27M
NVDA icon
16
NVIDIA
NVDA
$5.01T
$18.7M 1.18%
635,340
+210,730
+50% +$5.8M
ESTC icon
17
Elastic
ESTC
$7.15B
$18.5M 1.17%
150,645
+20,849
+16% +$3.15M
IIPR icon
18
Innovative Industrial Properties
IIPR
$1.7B
$18.1M 1.14%
68,762
+4,228
+7% +$1.08M
GTLS
19
DELISTED
Chart Industries
GTLS
$18M 1.14%
113,060
+7,370
+7% +$1.3M
HZNP
20
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$17.4M 1.1%
161,063
+12,818
+9% +$1.4M
RRR icon
21
Red Rock Resorts
RRR
$3.84B
$17M 1.07%
308,233
+28,328
+10% +$1.47M
BILL icon
22
BILL Holdings
BILL
$4.7B
$16.9M 1.07%
67,913
+23,226
+52% +$6.57M
ESTA icon
23
Establishment Labs
ESTA
$2.73B
$16.9M 1.07%
249,664
+49,294
+25% +$3.45M
SPG icon
24
Simon Property Group
SPG
$74.3B
$16.8M 1.06%
105,082
+24,600
+31% +$3.75M
BX icon
25
Blackstone
BX
$108B
$16.8M 1.06%
129,632
+1,850
+1% +$247K
1
2 3 4 5

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Nicholas Investment Partners held 221 positions worth $1.58B, up 15% from $1.37B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners deployed $71.1M of net new capital in Q4 2021, opening 32 new positions and adding to 92 existing holdings. Its largest new stake was P3 Health Partners: 21,075 shares worth $7.42M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 36% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Ginkgo Bioworks, an estimated $8.89M trimmed.

  • Nicholas Investment Partners's largest Q4 2021 buy was P3 Health Partners: 21,075 shares worth $7.42M.
  • Nicholas Investment Partners added most to Ascendis Pharma A/S in Q4 2021, an estimated $12.6M increase.
  • Nicholas Investment Partners's biggest Q4 2021 reduction was Ginkgo Bioworks, cutting an estimated $8.89M.
  • Nicholas Investment Partners fully exited Amyris Inc. in Q4 2021, selling an estimated $13M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $1.58B portfolio in Q4 2021.
  • Nicholas Investment Partners opened 32 new positions and closed 27 in Q4 2021.
  • Nicholas Investment Partners's portfolio value rose 15% quarter-over-quarter to $1.58B.

Based on Nicholas Investment Partners's 13F filing for Q4 2021, filed 14 Feb 2022.